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Internal ribosome entry sites (IRESs) are
specialized mRNA elements that allow
recruitment of eukaryotic ribosomes to
naturally uncapped mRNAs or to capped
mRNAs under conditions when cap-
dependent translation is inhibited. Putative
cellular IRESs have been proposed to play
crucial roles in stress responses, development,
apoptosis, cell-cycle control, and neuronal
function. However, most of the evidence for
cellular IRES activity rests on bicistronic
reporter assays whose reliability has been
questioned. Here, the mechanisms underlying
cap-independent translation of cellular
mRNAs, and the contributions of such
translation to cellular protein synthesis, are
discussed. We suggest that the division of
cellular mRNAs into mutually exclusive
categories of ‘cap-dependent’ and ‘IRES-
dependent’ should be reconsidered, and that
the implications of cellular IRES activity need
to be incorporated into our models of cap-
dependent initiation.
____________________________________
Eukaryotic mRNAs are modified by the
addition of an m7GpppN cap structure to their 5’
ends. The m7G cap is thought to stimulate
translation of most mRNAs by enhancing
binding of a 43S pre-initiation complex
(containing 40S ribosomal subunits, methionine
initiator tRNA, and initiation factors eIF2 and
eIF3) to 5’ untranslated regions (5’UTRs) of
mRNAs through recognition of the m7G cap by
a complex of the cap-binding protein, eIF4E, a
large scaffold protein, eIF4G, and an ATP-
dependent RNA helicase, eIF4A.   Subsequent
movement of the 43S complex in a 5’ to 3’
direction (scanning) locates the initiating AUG
through recognition by the anticodon of the
initiator tRNA.  The discovery that naturally
uncapped picornaviral mRNAs can efficiently
recruit the host cell’s translation machinery via
internal ribosome entry sites – IRESs – raised
the possibility that certain cellular mRNAs
might have a similar capability (1, 2).
The cellular IRES hypothesis offered an
attractive solution to two problems. First, a
number of cellular stress responses involve
inhibition of one or more general translation
initiation factors, yet the adaptive responses to
stress require new protein synthesis. Cellular
IRES elements could allow mRNAs encoding
key regulatory proteins to escape the general
inhibition of translation. The observation that
some cellular mRNAs continue to be translated
in poliovirus infected cells after the inhibition of
cap-dependent initiation (through cleavage of
eIF4G by a virally encoded protease) is
consistent with this hypothesis (3). Second, the
existence of cellular IRESs could explain how
mRNAs having very long 5’UTRs, or containing
numerous predicted stem-loop structures or
upstream AUGs within their 5’UTRs, could be
translated with reasonable efficiency, despite
evidence that such features can significantly
reduce translation of model mRNAs (4-6).
Both arguments in favor of the cellular IRES
hypothesis rest on certain assumptions about the
predominant mechanism of cap- and scanning-
dependent initiation that this review will re-
examine in light of recent publications that (i)
demonstrate that long, GC-rich 5’UTRs can be
efficiently translated by a cap-dependent
mechanism, in contrast to the prevailing view,
and (ii) reveal the surprising range of
translational efficiencies displayed by cellular
mRNAs under conditions where cap-dependent
initiation is presumed to be the predominant
mechanism for translation.
To be clear, it is not the intention of this
reviewer to deny the existence of cellular IRESs,
nor to discourage newcomers to the translational
control field from testing their favorite genes for
IRES activity. Rather, one purpose of this
discussion is to ensure that such newcomers do
not fall victim to either the logical or the
experimental pitfalls that have plagued the
cellular IRES field. The ultimate goals of this
field are to understand both the molecular
mechanisms underlying cap-independent
initiation, and the physiological function(s) of
cellular IRES-dependent translation. Because
neither of these purposes is served when 5’UTRs
are erroneously claimed to promote IRES-
dependent initiation, we begin by discussing the
source of most such errors.
The Pitfalls of Bicistronic Reporter Assays –
Eukaryotic ribosomes do not efficiently re-
initiate translation of a downstream open reading
frame (ORF) after translating a full-length ORF
located upstream in the same mRNA.  If,
however, the downstream ORF is preceded by
an IRES, internal ribosome recruitment can
result in high levels of translation of the second
cistron. Based on this property, bicistronic
reporters have been used to investigate the cis-
acting elements required for viral IRES activity
(7). A typical bicistronic reporter construct is
illustrated below (Figure 1). Such reporters have
also been employed to test cellular 5’UTRs’
capacity for IRES-dependent initiation. It will be
immediately clear to most readers that the
insertion of a promoter sequence in between the
two cistrons will also promote reporter activity
from the downstream cistron, by activating
transcription of a capped monocistronic mRNA.
In principle, it seems straightforward to
distinguish between these two mechanisms by
determining whether or not the inserted
sequence leads to the production of
monocistronic messages. In practice, despite
abundant evidence that cryptic promoter artifacts
are widespread in the cellular IRES literature (8-
16), most publications claiming cellular IRES
activity do not include controls that are adequate
to determine whether a candidate sequence
really is an IRES and not a cryptic promoter.
Why is this the case?
Most putative cellular IRESs are much less
active than their viral counterparts when tested
in assays that reliably measure translational
activity (in vitro translation, or in vivo
translation of transfected in vitro-transcribed
mRNAs) (8, 9, 16). While it is true that the
presumed raison d’être of most cellular IRESs –
to permit expression of key regulatory proteins,
often of low abundance, under conditions of
global inhibition of cap-dependent translation –
does not require that cellular IRES-dependent
initiation be nearly as efficient as viral IRES-
dependent translation (which typically drives
unregulated high-level expression of viral
proteins), the very low level of activity of most
putative cellular IRESs makes it far more
difficult to rule out alternative explanations for
activity in bicistronic reporter assays –
mechanisms that do not involve translation at
all, such as cryptic promoter activity. The use of
extremely sensitive reporters like Firefly
luciferase permits detection of protein produced
from almost undetectably small quantities of
m7G capped monocistronic mRNA. A typical
Northern blot exposure is simply not adequate to
rule out the possibility that 1% of the total
mRNA encoding the 3’ cistron is monocistronic.
This is the appropriate level of detection to
consider for most putative cellular IRESs, whose
demonstrably IRES-dependent translation is
only ~1% as efficient as cap-dependent
translation of a control reporter mRNA (8, 9,
16). It is important to note that the popular
Renilla/Firefly luciferase reporter is not the only
bicistronic reporter system vulnerable to cryptic
promoter artifacts. The βgal/CAT reporter
system has been shown to produce similar
results (14).
No matter what reporter is used, the induction of
3’ cistron expression through non-translational
mechanisms must be rigorously excluded before
cellular IRES activity is concluded. A number of
appropriate controls have been proposed,
including showing very overexposed Northern
blots, using siRNAs targeting the 5’ cistron of
bicistronic mRNAs, and testing candidate IRESs
for promoter activity in vectors that retain the
SV40 enhancer element (but omit the SV40
promoter). Each of these control experiments
behaves as expected for true IRES-dependent
initiation when tested with viral UTR sequences
such as the encephalomyocarditis virus (EMCV)
IRES. Notably, most cellular IRES publications
do not undertake such tests, and when tested,
many putative cellular IRESs fail (8-16).
The DNA-based bicistronic reporter assay is not
hopelessly flawed. The use of tightly regulated
inducible promoters to drive expression of
bicistronic mRNAs in vivo can permit
discrimination between translational activation
of the downstream cistron by an IRES, in which
case activity from the downstream reporter will
disappear in parallel with the upstream reporter
when the 5’ promoter is repressed, and
transcriptional activation via the insertion of a
promoter, in which case activity of the two
reporters will be uncoupled (17, 18). Note that
the presence of promoter activity, cryptic or
otherwise, does not rule out the possibility that a
sequence may normally function as an IRES (the
HCV IRES is an example of such a sequence),
but it necessitates the use of some assay other
than DNA transfection of bicistronic reporters to
study the putative IRES’s activity.
Cellular IRESs, Weak and Strong – So, are
there cellular 5’UTRs with unambiguous IRES
activity? Yes. A number of cellular 5’UTRs
stimulate translation of uncapped mRNA, and/or
promote translation of 3’cistrons in RNA-based
reporter assays that eliminate the possibility of
cryptic promoter activity (9, 16, 19-21). The
question is, how much does IRES-dependent
initiation contribute to the overall level of
protein synthesis for IRES-containing genes?
As noted above, most cellular IRESs promote
translation that is very inefficient (<2%) when
compared to cap-dependent translation of
control reporters. Not all cellular IRESs are so
weak. Internal initiation at AUG94 of the URE2
gene of S. cerevisiae occurs ~22% as often as
cap-dependent initiation at the first AUG under
normal growth conditions, and ~50% as often
under conditions when cap-dependent initiation
is reduced by a mutation in the cap binding
protein (22). This level of IRES activity is
comparable to viral IRESs. Importantly, the
truncated protein produced by internal initiation
at AUG94 has distinct functional properties,
suggesting mechanisms whereby IRES-
dependent initiation could affect cellular
physiology. The authors ruled out IRES-
independent mechanisms for the efficient
production of the C-terminal fragment of Ure2p,
including proteolysis of full-length protein and
leaky scanning past the first AUG initiation
codon. Heavily exposed Northern blots showed
no signs of a smaller mRNA species (22), and
sequencing of full-length cDNAs revealed
transcription start sites between –216 and –208
exclusively (23).
URE2 is not the only cellular IRES with activity
comparable to viral IRESs. Other yeast cellular
IRESs show similarly high activity in in vitro
translation assays (19). Furthermore, strong
cellular IRES activity is not restricted to yeast.
The 5’UTR of mammalian c-Src contains a
potent IRES, having >80% of the activity of
poliovirus IRES by in vitro translation assays,
and >100% of the activity of HCV IRES in in
v i v o  RNA transfection experiments. In a
bicistronic m7G-Renilla-IRES-Firefly reporter
mRNA, translation initiation by the c-Src IRES
produced a Firefly/Renilla ratio of greater than
one (24).
Given that some cellular IRESs show activity
comparable to viral IRESs, and within the same
order of magnitude as efficiently translated
m7G-capped mRNAs, what are we to make of
cellular IRESs that are <2% as efficient as cap-
dependent controls? It has been argued that this
is not the relevant comparison. Control m7G-
capped mRNAs usually have short 5’UTRs that
are thought to mediate very efficient initiation.
In contrast, most reported cellular IRESs are
found in mRNAs with unusually long 5’UTRs
predicted to form extensive RNA secondary
structures and therefore presumed incapable of
mediating efficient cap-dependent initiation.
Furthermore, cellular IRESs are generally
proposed to function under conditions where
cap-dependent translation is inhibited.
The Presumption of Inefficient Cap-
dependent Initiation – Predicted 5’UTR RNA
secondary structure is frequently invoked as a
reason a gene might require an IRES for
efficient translation. The evidence for an
inhibitory effect of RNA secondary structure
seems clear from experiments using artificial
5’UTRs with hairpins of defined stability and
placement within the 5’UTR (4-6 ). It was
therefore quite surprising when the long GC-rich
5’UTRs of several putative cellular IRES-
dependent genes (including HIF-1α, c-Myc, and
Apaf-1) were found to mediate cap-dependent
translation nearly as efficiently as the 5’UTR
from β-globin or a short unstructured control
5’UTR. Even somewhat less efficiently
translated 5’UTRs were translated almost
exclusively by a cap-dependent mechanism (8,
9). Clearly, our current understanding of what
makes an mRNA amenable to cap-dependent
translation is insufficient to allow accurate
predictions. To avoid this pitfall in the future,
researchers should directly compare the
efficiencies of cap-dependent and IRES-
dependent translation mediated by a given
5’UTR. One cannot conclude that any 5’UTR,
no matter how long or burdened with
‘inhibitory’ features like predicted stem-loops or
AUG codons, is poorly translated via cap-
dependent initiation without direct experimental
evidence.
How strongly is cap-dependent translation
inhibited under conditions where cap-
independent initiation is proposed to
predominate? Glucose withdrawal causes a 10-
to 20-fold reduction in global protein synthesis
by a mechanism that requires the decapping
machinery (25, 26). A cap-independent
mechanism of translation that was only 10% as
efficient as cap-dependent initiation under
normal growth conditions could nevertheless be
responsible for the majority of new protein
synthesis in starved cells, if the mechanism of
‘global’ inhibition were specific to cap-
dependent initiation. Hypoxia is another cellular
stress that causes global down-regulation of
translation, and for which cellular IRES-
dependent translation has been suggested to be
important for the adaptive response. Might a
mechanism that is 2% as efficient as cap-
dependent initiation contribute significantly to
overall levels of protein synthesis? Given recent
work showing that global translation decreases
by 20-70% during oxygen deprivation, it seems
unlikely (16). One should carefully consider
both the extent of inhibition of cap-dependent
initiation, and the relative efficiencies of cap-
dependent and IRES-dependent translation of a
given gene, when trying to determine the likely
biological role of a 5’UTR with IRES activity.
There may be dedicated cellular IRESs, 5’UTRs
that are incapable of cap-dependent initiation, as
well as local cellular environments where cap-
dependent initiation is so strongly inhibited as to
render even inefficient cellular IRESs
physiologically relevant, but this needs to be
demonstrated experimentally. Something is
wrong when a study revealing that a putative
cellular IRES is actually a cryptic promoter is
followed by a subsequent study investigating the
regulation of said ‘cellular IRES’ activity using
transfection of bicistronic DNA reporters.
The Role of RNA Tertiary Structure in
Cellular IRES Activity – Is There One? – The
nature and function of RNA structures in a
variety of viral IRESs that use different
mechanisms to initiate has recently been
reviewed (27). There is reason to suspect that
cellular IRESs may also use a variety of
mechanisms. Here we consider the evidence that
cellular IRESs rely on the formation of defined
RNA structures that functionally substitute for
one or more translation factors in order to recruit
ribosomes. Mammalian c-Src is a good
candidate for a dedicated cellular IRES gene, as
addition of an m7G-cap does not stimulate
translation of mRNA containing the c-Src
5’UTR (24). This observation is also consistent
with the hypothesis that the c-Src 5’UTR is
extensively folded, as predicted in silico. While
it is tempting to speculate that c-Src’s cellular
IRES activity depends on the formation of a
defined RNA tertiary architecture, similar to
structured viral IRESs, this need not be the case.
The IRES-containing YMR181c 5’UTR is
extensively folded, at least in vitro, yet deletion
of the structured 5’ portion of the 5’UTR has no
effect on IRES activity (19). In contrast, the
U R E 2  IRES does appear to require RNA
structure for full activity, but the minimal IRES
is both smaller and less structured than well-
characterized viral IRESs (18, 28).
Hints that viral-like structured cellular IRESs
may exist can be found in studies of mutants
with reduced translation from the structured
cricket paralysis virus (CrPV) IRES (17, 29). In
yeast lacking the non-essential ribosomal protein
Rps25, CrPV IRES activity is reduced by 97%.
Cellular protein synthesis, measured by 35S-
methionine incorporation, was reduced by 19%.
Polysome analysis showed a similarly modest
decrease in the polysome to monosome ratio in
the rps25Δ strain, consistent with a mild defect
in translation initiation (17). The identities of the
affected cellular mRNAs were not determined,
but it is tempting to speculate that at least some
of them might require a specific interaction
between their 5’UTRs and the 40S subunit of the
ribosome for efficient translation initiation. It
seems unlikely that 19% of normal yeast protein
synthesis proceeds via a CrPV IRES-like
initiation mechanism, but this possibility cannot
yet be ruled out. Alternatively, our models for
cap-dependent initiation must be altered to
explain why certain mRNAs require a specific
non-essential ribosomal protein for their
translation.
In summary, the jury is still out on whether
viral-like structured cellular IRESs exist. Even if
they exist, they may not be the norm for cellular
IRESs. In other aspects of mRNA metabolism,
such as messenger RNA export, eukaryotic host
cells employ diverse RNA-binding proteins to
do a job that is performed by structured viral
RNA elements (30). This may reflect a trade-off
between constitutive efficiency in viral gene
expression and a need for regulation in cellular
gene expression.
Dedicated IRES or Translational Enhancer?
– Does the capacity of a 5’UTR to promote
IRES-dependent initiation, even in cases where
the IRES-dependent mechanism is quite
efficient, necessarily mean that a particular
protein is synthesized by a cap-independent
mechanism? In the literature, ‘has an IRES’ is
often taken to mean ‘is normally translated via
internal ribosome entry’. This is a dangerous
assumption. Unlike some viral mRNAs, cellular
IRES-containing mRNAs are generally capped.
A 5’UTR element that is capable of promoting
internal ribosome entry might also function as an
enhancer of cap-dependent initiation, depending
on its mechanism of action. For example, some
yeast cellular IRESs enhance the recruitment of
eIF4G via binding of the poly(A)-binding
protein to A-rich elements within 5’UTRs (19).
Unless tightly folded intervening RNA elements
are present to preclude a productive interaction
between eIF4E bound to the cap and eIF4G
recruited more internally, there is no reason a
priori to assume that internal 5’UTR elements
could not act synergistically with the m7G cap to
increase the overall efficiency of initiation. Such
a capability could permit some mRNAs to be
preferentially translated under conditions where
global cap-dependent initiation is reduced but
not abolished.
The purpose of this discussion is not to dwell on
possible errors of interpretation in the cellular
IRES literature, but to suggest that mechanistic
studies of cellular IRES-dependent initiation
ought to be reconsidered in light of what they
may be telling us about the mechanism(s) of
eukaryotic translation. Whether or not a
particular gene is likely to rely on a cap-
independent mechanism of protein synthesis, the
fact that some 5’UTRs, but not others, are
capable of recruiting the eukaryotic translation
machinery internally, is interesting. The
prevailing model for cap-dependent initiation
treats 5’UTRs as passive substrates that
contribute nothing to the recruitment of
ribosomes. According to this model, most
mRNAs are translated by a constitutive
mechanism whose efficiency is largely
determined by the global availability of active
initiation factors. Deviations from the ‘typical’
(read: idealized) 5’UTR are presumed to affect
translation negatively. Consistent with this view,
most examples of 5’UTR-mediated translational
control involve inhibition of cap-dependent
initiation. (Reviewed in (31).)
Why shouldn’t there also be enhancers of cap-
dependent translation? The core eukaryotic
translation initiation machinery includes several
proteins known to have direct RNA-binding
capacity, which viruses exploit. The IRESs of
poliovirus and EMCV bind specifically to
eIF4G; the HCV IRES binds eIF3 as well as the
40S subunit; the CrPV IRES binds ribosomes
directly (27). It is unlikely to be true that all
cellular 5’UTRs have identical affinities for all
factors. Indeed, genome-wide studies
investigating the consequences of reducing the
activity of the ‘core’ cap-dependent initiation
factor eIF4G reveal striking gene-specific
consequences, rather than uniform reduction of
translation of most mRNAs (32, 33). This is
analogous to recent studies in the splicing field,
in which reductions in different ‘core’
components of the splicing machinery were
shown to cause intron-specific effects in both
yeast and metazoans (34, 35). One could argue
that certain mRNA transcripts are inherently
poor substrates for the splicing or translation
machineries, and are therefore sensitized to
partial loss-of-function conditions. This
‘sensitive substrate’ model doesn’t adequately
explain why genes would respond differentially
to reductions of some but not other core
components, if one envisions a single pathway
taken by all genes. An alternative model
proposes that specific interactions between
individual 5’UTRs and RNA-binding translation
factors contribute significantly to the efficiency
of some genes’ translation.
Even under growth conditions when ‘standard’
cap-dependent translation is presumed to
predominate, yeast genes’ translational
efficiencies vary by two orders of magnitude
(36). This surprising conclusion was reached
using an elegant new method developed by
Ingolia, Weissman, and colleagues. Their
method, ribosome footprint profiling, permits
quantitative measurement in vivo of translational
efficiency genome-wide, and is capable of
confidently distinguishing small changes in
translation over a large dynamic range. We have
repeated these experiments in our laboratory,
and see similar results (M.K. Thompson and
WG, unpublished observations). Even if one
allows for five-fold differences in translational
efficiency to be ignored, which is generous
given that the replicate error of measurement is
less than 1.5-fold, there is still a lot of variation
to be explained as illustrated in Figure 2.  For
the ~200 genes that are translated with very low
efficiency (lower than GCN4, which is known to
be poorly translated in rich media), one could
argue that each of these mRNAs is burdened
with a ‘bad’ 5’UTR. But how shall we explain
the hundreds of genes that are translated much
more efficiently than the average yeast gene?
Although it remains to be seen how much of this
variability is due to differences in 5’UTR
features, translation studies of putative cellular
IRESs may be informative.
Whereas most mechanistic studies of cap-
dependent initiation have focused on a very
limited collection of mRNA substrates, the
cellular IRES field has investigated the
molecular requirements for translation of a more
diverse group of 5’UTR constructs. Assays for
cellular IRES activity artificially force 5’UTRs
to rely exclusively on internal ribosome entry,
thereby revealing contributions to translation
that do not require recognition of the m7G cap
by eIF4E. Most yeast cellular IRESs
characterized to date show activity that is
strongly affected by the level of eIF4G (19).
Some of these eIF4G-dependent IRES-
containing genes are among the yeast genes that
are very efficiently translated in rapidly dividing
cells: PAB1 , TIF4632, NCE102 , and GIC1.
(Figure 2) One attractive hypothesis to explain
this observation is that 5’UTR sequences that are
capable of recruiting eIF4G in the absence of
eIF4E greatly enhance the efficiency of
translation in the presence of eIF4E and an m7G
cap. Several mammalian 5’UTRs that are
capable of (relatively inefficient) IRES-
dependent initiation are translated with
surprising efficiency in a cap-dependent context,
given that these 5’UTRs are quite long and GC-
rich (8, 9). These 5’UTR’s in vitro IRES activity
is strongly dependent on the level of eIF4G (20).
eIF4A may also act as an mRNA-specific
translational enhancer. Cap-independent
translation of mRNAs containing the c-Myc or
BiP 5’UTRs was strongly stimulated by
increased levels of eIF4A, compared to a control
m7G-capped reporter containing an artificial 56-
nucleotide 5’UTR (21). Selective recruitment of
multiple molecules of eIF4A to certain 5’UTRs
could explain why eIF4A is several-fold more
abundant than eIF4E in yeast (37) (38). These
results are consistent with the model that
specific recruitment of a general initiation factor
can lead to enhanced cap-dependent initiation,
and permit some level of cap-independent
initiation, as depicted in Figure 3. The m7G cap
may also cooperate with the cellular IRES
element to facilitate initiation, for example by
increasing the local concentration of eIF4F.
Thus, a stimulatory effect of the m7G cap on
translation does not necessarily reflect the use of
a canonical cap-dependent initiation mechanism.
Cellular 5’UTRs may also contain translational
enhancer elements that recruit dedicated RNA-
binding proteins. Such enhancers of cap-
dependent initiation need not be large RNA
elements. In the case of splicing enhancers, six
nucleotide elements are sufficient to stimulate
splicing several fold (39). This likely involves
the recognition of the enhancer element by
specific RNA-binding proteins that subsequently
bind to and stabilize the association of one or
more spliceosome components with the pre-
mRNA. While it is not yet clear how many
RNA-binding proteins might similarly bridge
interactions between cellular 5’UTRs and the
translation machinery, even the relatively small
yeast genome is predicted to encode more than
300 RNA-binding proteins (exclusive of
ribosomal proteins), each with a specific set of
RNA targets (40). Precedent for this mode of
translational enhancement by specific RNA-
binding proteins exists in the form of 5’UTRs
that specifically bind Pab1 to enhance
recruitment of eIF4G in yeast, and neuronal
mRNAs that specifically bind HuD to enhance
recruitment of eIF4A in mammals (19, 41).
Some of the RNA-binding proteins proposed to
act as IRES trans-activating factors (ITAFs) may
function similarly. Of course, RNA-binding
proteins might also regulate translation by
antagonizing the activity of a translational
enhancer element.
Concluding Remarks – Most 5’UTRs with
cellular IRES activity can be efficiently
translated by a cap-dependent mechanism,
despite the presence of features (unusual length,
GC-richness, predicted RNA structure, upstream
AUGs) long presumed to inhibit cap-dependent
initiation. The significance of this fact is only
beginning to be appreciated. In future work,
researchers investigating the mechanisms of
eukaryotic translation initiation, whether cap-
dependent or IRES-dependent, will need to
account for the surprising range of in vivo
translational efficiencies revealed by new high-
throughput methods. It seems likely that many
molecular connections linking specific 5’UTR
sequences, RNA-binding proteins, and the
translation machinery remain to be discovered.
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Figure legends
Figure 1 – A typical bicistronic reporter plasmid used for IRES assays. A strong promoter such as SV40
drives expression of a bicistronic mRNA. Renilla luciferase activity reports the level of cap-dependent
initiation in the experiment. Firefly luciferase activity is very low unless the intercistronic region contains
an IRES or a promoter.
Figure 2 – Genome-wide measurements reveal large differences in translation efficiency under conditions
where the canonical cap-dependent initiation mechanism is presumed to predominate. Translational
efficiency is determined by comparing the amount of ribosome-associated mRNA to the total pool of
mRNA for each gene. The data are normalized such that the median translational efficiency is equal to 1
(log2 = 0). Some genes with unusual translational efficiencies are highlighted and discussed in the text.
The data are for wild type yeast grown in rich media, from Ingolia et al. 36
Figure 3 – Mechanisms of 5’UTR-mediated translational enhancement. (A) According to the canonical
model of cap-dependent eukaryotic ribosome recruitment, the only specific point of contact between the
5’UTR and the translation machinery is the m7G cap, which is bound by eIF4E. (B) Other eIFs, including
eIF4G, -4A, and -4B, have RNA binding activity, which viral IRESs such as EMCV exploit for efficient
cap-independent ribosome recruitment. (C) Cellular 5’UTRs may also use translational enhancer elements
(shown as color-coded boxes along the RNA) to recruit the translation machinery, via either cap-
stimulated or cap-independent pathways. Sequence-specific RNA-binding proteins (RBP) can bridge
interactions between 5’UTR elements and general translation factors.
Working abbreviations used:
IRES – internal ribosome entry site
eIF – eukaryotic initiation factor
UTR – untranslated region
RBP – RNA binding protein
EMCV – Encephalomyocarditis virus
HCV – Hepatitis C virus
CrPV – Cricket Paralysis virus
Examples cited with abbreviations (gene names):
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